REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nibec Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Nibec Co.,Ltd. Profile Updated: January 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Nibec Co.,Ltd. is engaged in manufacturing and selling of peptide smart materials. The company offers peptide-based bio fusion products, biomaterials for tissue regeneration, cosmetics, and oral care products. Nibec Co.,Ltd. was incorporated in 2004 and is based in Incheon, South Korea.

Headquarters
1127 Sinwol-Ri, Iwol-Myeon, Jincheon-Gun
Chungcheongbuk-Do; Postal Code: 365-824

Contact Details: Purchase the Nibec Co.,Ltd. report to view the information.

Website: http://www.nibec.co.kr

Basic Information
Total Employees:
Purchase the Nibec Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Nibec Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Nibec Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Nibec Co.,Ltd. report to view the information.
Incorporation Date:
February 20, 2004
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
26.39%
Purchase this report to view the information.
6.54%
Purchase this report to view the information.
0.36%
Purchase this report to view the information.
0.36%
Purchase this report to view the information.
0.18%
Company Performance
Financial values in the chart are available after Nibec Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-33.03%▼
Total operating revenue
-29.18%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
17.45%▲
Total equity
4.68%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
11.42%▲
Quick Ratio
1.17%▲
Cash Ratio
0.89%▲

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Orient Bio Inc.
 
GL Pharm Tech Corp.
Optipharm Co.,Ltd
 
Kangstem Biotech Co., Ltd.
Cheil Bio Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo